跳至主要内容
临床试验/NL-OMON54725
NL-OMON54725招募中不适用

on-invasive axillary lymph node staging in breast cancer with PET/MRI - PET/MRI in node negative breast cancer

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 125 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
125

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Female patient with histologically confirmed breast cancer and clinically
  • confirmed negative lymph nodes in the axilla, scheduled to undergo SLNB
  • 2. Patients who are willing and able to undergo the study procedures
  • 3. The patient has provided personally written informed consent

排除标准

  • 1. Patients treated with neoadjuvant systemic therapy prior to axillary nodal
  • 2. Patients with clinically positive axillary lymph nodes
  • 3. Age < 18 years
  • 4. Inability to provide informed consent
  • 5. Pregnancy
  • 6. Weight >100 kg (because of the format of the PET/MRI scanner)
  • 7. General contraindications for MRI (such as pacemaker, aneurysm clips,
  • metallic device in their body, severe claustrophobia) or PET (i.e. known
  • allergy to 18F-FDG)
  • 8. Hyperglycaemia (> 11 mmol/L) at the time of 18F-FDG injection

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验